maintain weightloss from glp-1 metairie Slimmetry Medical Center GLP-1 Weight Loss Specialist in

The landmark SURMOUNT-1 trial followed participants for 72 weeks (approximately 18 months), demonstrating continued weight reduction throughout the study period

It has gained popularity not only for its effectiveness in controlling glucose levels but also for its potential benefits in managing weight

Simon, A., Monier, F., Emonard, H., Gillery, P., Hornebeck, W., Maquart, F., & Birembaut, P

[8] SURPASS-2 : Tirzepatide (5, 10, 15 mg) reduced HbA1c by 2.01%2.30%, compared to 1.86% with semaglutide (1 mg)

When Rodriguez increased the dosage too quickly, she was "sick as a dog" and threw up every day, but then went back down briefly and was OK, she said